Humana Inc (HUM) Stock Price and Analyst Predictions

Humana Inc (NYSE: HUM) has a price-to-earnings ratio that is above its average at 26.59x. The stock has a 36-month beta value of 0.62. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 3 as “overweight,” 18 as “hold,” and 0 as “sell.”

The public float for HUM is 120.43M, and at present, short sellers hold a 3.04% of that float. On March 19, 2025, the average trading volume of HUM was 1.63M shares.

HUM) stock’s latest price update

The stock price of Humana Inc (NYSE: HUM) has plunged by -1.83 when compared to previous closing price of 269.78, but the company has seen a 6.31% gain in its stock price over the last five trading sessions. zacks.com reported 2025-03-18 that HUM’s CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.

HUM’s Market Performance

Humana Inc (HUM) has experienced a 6.31% rise in stock performance for the past week, with a 2.95% rise in the past month, and a -3.39% drop in the past quarter. The volatility ratio for the week is 3.24%, and the volatility levels for the past 30 days are at 3.46% for HUM. The simple moving average for the last 20 days is 1.97% for HUM stock, with a simple moving average of -13.42% for the last 200 days.

Analysts’ Opinion of HUM

Many brokerage firms have already submitted their reports for HUM stocks, with BofA Securities repeating the rating for HUM by listing it as a “Neutral.” The predicted price for HUM in the upcoming period, according to BofA Securities is $308 based on the research report published on November 06, 2024 of the previous year 2024.

Bernstein gave a rating of “Outperform” to HUM, setting the target price at $308 in the report published on October 08th of the previous year.

HUM Trading at -2.35% from the 50-Day Moving Average

After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.84% of loss for the given period.

Volatility was left at 3.46%, however, over the last 30 days, the volatility rate increased by 3.24%, as shares sank -0.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.90% upper at present.

During the last 5 trading sessions, HUM rose by +6.31%, which changed the moving average for the period of 200-days by -23.76% in comparison to the 20-day moving average, which settled at $259.73. In addition, Humana Inc saw 4.38% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HUM starting from Huval Timothy S., who proposed sale 1,247 shares at the price of $258.58 back on Feb 24 ’25. After this action, Huval Timothy S. now owns shares of Humana Inc, valued at $322,443 using the latest closing price.

Huval Timothy S., the Chief Administrative Officer of Humana Inc, sale 3,703 shares at $256.26 during a trade that took place back on Dec 31 ’24, which means that Huval Timothy S. is holding 8,181 shares at $948,925 based on the most recent closing price.

Stock Fundamentals for HUM

Current profitability levels for the company are sitting at:

  • 0.02 for the present operating margin
  • 1.0 for the gross margin

The net margin for Humana Inc stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 7.40, with 2.59 for asset returns.

Based on Humana Inc (HUM), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 3.88.

Currently, EBITDA for the company is 3.53 billion with net debt to EBITDA at 2.69. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 43.55for trailing twelve months and the total asset turnover is 2.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.76.

Conclusion

To sum up, Humana Inc (HUM) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts